76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
76%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
76%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Straumann Holding AG
Closed
SectorHealthcare
112.65 0.18
Overview
Share price change
24h
Min
111.5
Max
114.2
Income | -40M 191M |
|---|---|
Sales | -43M 1.2B |
P/E Sector Avg | 39.073 56.602 |
Dividend yield | 0.85 |
Profit margin | 15.499 |
Employees | 11,342 |
EBITDA | 7.5M 416M |
Recommendations | Buy |
|---|---|
12 Months Forecast | +23.22% upside |
Dividend yield Sector Avg | 0.85% 2.45% |
|---|---|
Next Earnings | 13 Aug 2025 |
Market Cap | 1.8B 18B |
|---|---|
Previous open | 112.47 |
Previous close | 112.65 |
News Sentiment
By Acuity
50%
50%
173 / 382 Healthcare
Straumann Holding AG Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Straumann Holding AG Forecast
Price Target
By TipRanks
23.22% upside
12 Months Forecast
Average 138.13 CHF 23.22%
High 160 CHF
Low 96 CHF
Based on 8 Wall Street analysts offering 12 month price targets forStraumann Holding AG - Dist in the last 3 months.
Sentiment
By Acuity
173 / 382 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Straumann Holding AG
Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.
